Frontlight ResearchEarly access
Trial site
Carolina Cancer Research Center
- 7running trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Bladder cancer1 trial
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Head and neck cancer1 trial
- Kidney cancer1 trial
- Liver and biliary tract cancer1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- Ovarian cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 35 trials
- Phase 11 trial
- Phase 21 trial
- Status
- Recruiting6 trials
- Active, not recruiting1 trial
- Lead sponsor
- Pfizer2 trials
- Daiichi Sankyo1 trial
- Eli Lilly and Company1 trial
- Janssen Research & Development, LLC1 trial
- Pliant Therapeutics, Inc.1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Recruiting
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer4 recruiting
- Bladder cancer1 recruiting
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
- Head and neck cancer1 recruiting
- Kidney cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Melanoma1 recruiting
- Metastatic breast cancer1 recruiting
- Ovarian cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026